Diagnostic imaging agents with MMP inhibitory activity
The present invention relates to the field of diagnostic imaging. Specifically, the invention relates to the diagnostic imaging of diseases where specific matrix metalloproteinases are known to be involved. One embodiment of the invention is a compound having matrix metalloproteinase inhibitory acti...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Storey, Anthony Davis, Julie Ricketts, Sally-Ann Mendizabal, Marivi Cuthbertson, Alan Arukwe, Joseph Heywood, Kirsty Wilson, Ian Wynn, Duncan Schafers, Michael Levkau, Bodo Wagner, Stefan Breyholz, Hans-Jörg Kopka, Klaus |
| description | The present invention relates to the field of diagnostic imaging. Specifically, the invention relates to the diagnostic imaging of diseases where specific matrix metalloproteinases are known to be involved. One embodiment of the invention is a compound having matrix metalloproteinase inhibitory activity suitable for diagnostic imaging. Also disclosed in the present invention is a pharmaceutical composition comprising the diagnostic imaging agent of the invention in a form suitable for mammalian administration. The invention furthermore discloses intermediates in the synthesis of the diagnostic imaging agents of the invention and kits for the preparation of the pharmaceutical composition of the invention. The pharmaceutical composition of the invention may be used in the diagnosis of diseases where specific matrix metalloproteinases are known to be involved. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_08231858</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>08231858</sourcerecordid><originalsourceid>FETCH-uspatents_grants_082318583</originalsourceid><addsrcrecordid>eNrjZDBzyUxMz8svLslMVsjMTUzPzEtXSExPzSspVijPLMlQ8PUNUMjMy8hMyizJL6pUSEwuySzLLKnkYWBNS8wpTuWF0twMCm6uIc4euqXFBYklIO3x6UWJIMrAwsjY0MLUwpgIJQBwLC6I</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Diagnostic imaging agents with MMP inhibitory activity</title><source>USPTO Issued Patents</source><creator>Storey, Anthony ; Davis, Julie ; Ricketts, Sally-Ann ; Mendizabal, Marivi ; Cuthbertson, Alan ; Arukwe, Joseph ; Heywood, Kirsty ; Wilson, Ian ; Wynn, Duncan ; Schafers, Michael ; Levkau, Bodo ; Wagner, Stefan ; Breyholz, Hans-Jörg ; Kopka, Klaus</creator><creatorcontrib>Storey, Anthony ; Davis, Julie ; Ricketts, Sally-Ann ; Mendizabal, Marivi ; Cuthbertson, Alan ; Arukwe, Joseph ; Heywood, Kirsty ; Wilson, Ian ; Wynn, Duncan ; Schafers, Michael ; Levkau, Bodo ; Wagner, Stefan ; Breyholz, Hans-Jörg ; Kopka, Klaus ; GE Healthcare Limited</creatorcontrib><description>The present invention relates to the field of diagnostic imaging. Specifically, the invention relates to the diagnostic imaging of diseases where specific matrix metalloproteinases are known to be involved. One embodiment of the invention is a compound having matrix metalloproteinase inhibitory activity suitable for diagnostic imaging. Also disclosed in the present invention is a pharmaceutical composition comprising the diagnostic imaging agent of the invention in a form suitable for mammalian administration. The invention furthermore discloses intermediates in the synthesis of the diagnostic imaging agents of the invention and kits for the preparation of the pharmaceutical composition of the invention. The pharmaceutical composition of the invention may be used in the diagnosis of diseases where specific matrix metalloproteinases are known to be involved.</description><language>eng</language><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8231858$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64012</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/8231858$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Storey, Anthony</creatorcontrib><creatorcontrib>Davis, Julie</creatorcontrib><creatorcontrib>Ricketts, Sally-Ann</creatorcontrib><creatorcontrib>Mendizabal, Marivi</creatorcontrib><creatorcontrib>Cuthbertson, Alan</creatorcontrib><creatorcontrib>Arukwe, Joseph</creatorcontrib><creatorcontrib>Heywood, Kirsty</creatorcontrib><creatorcontrib>Wilson, Ian</creatorcontrib><creatorcontrib>Wynn, Duncan</creatorcontrib><creatorcontrib>Schafers, Michael</creatorcontrib><creatorcontrib>Levkau, Bodo</creatorcontrib><creatorcontrib>Wagner, Stefan</creatorcontrib><creatorcontrib>Breyholz, Hans-Jörg</creatorcontrib><creatorcontrib>Kopka, Klaus</creatorcontrib><creatorcontrib>GE Healthcare Limited</creatorcontrib><title>Diagnostic imaging agents with MMP inhibitory activity</title><description>The present invention relates to the field of diagnostic imaging. Specifically, the invention relates to the diagnostic imaging of diseases where specific matrix metalloproteinases are known to be involved. One embodiment of the invention is a compound having matrix metalloproteinase inhibitory activity suitable for diagnostic imaging. Also disclosed in the present invention is a pharmaceutical composition comprising the diagnostic imaging agent of the invention in a form suitable for mammalian administration. The invention furthermore discloses intermediates in the synthesis of the diagnostic imaging agents of the invention and kits for the preparation of the pharmaceutical composition of the invention. The pharmaceutical composition of the invention may be used in the diagnosis of diseases where specific matrix metalloproteinases are known to be involved.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZDBzyUxMz8svLslMVsjMTUzPzEtXSExPzSspVijPLMlQ8PUNUMjMy8hMyizJL6pUSEwuySzLLKnkYWBNS8wpTuWF0twMCm6uIc4euqXFBYklIO3x6UWJIMrAwsjY0MLUwpgIJQBwLC6I</recordid><startdate>20120731</startdate><enddate>20120731</enddate><creator>Storey, Anthony</creator><creator>Davis, Julie</creator><creator>Ricketts, Sally-Ann</creator><creator>Mendizabal, Marivi</creator><creator>Cuthbertson, Alan</creator><creator>Arukwe, Joseph</creator><creator>Heywood, Kirsty</creator><creator>Wilson, Ian</creator><creator>Wynn, Duncan</creator><creator>Schafers, Michael</creator><creator>Levkau, Bodo</creator><creator>Wagner, Stefan</creator><creator>Breyholz, Hans-Jörg</creator><creator>Kopka, Klaus</creator><scope>EFH</scope></search><sort><creationdate>20120731</creationdate><title>Diagnostic imaging agents with MMP inhibitory activity</title><author>Storey, Anthony ; Davis, Julie ; Ricketts, Sally-Ann ; Mendizabal, Marivi ; Cuthbertson, Alan ; Arukwe, Joseph ; Heywood, Kirsty ; Wilson, Ian ; Wynn, Duncan ; Schafers, Michael ; Levkau, Bodo ; Wagner, Stefan ; Breyholz, Hans-Jörg ; Kopka, Klaus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_082318583</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Storey, Anthony</creatorcontrib><creatorcontrib>Davis, Julie</creatorcontrib><creatorcontrib>Ricketts, Sally-Ann</creatorcontrib><creatorcontrib>Mendizabal, Marivi</creatorcontrib><creatorcontrib>Cuthbertson, Alan</creatorcontrib><creatorcontrib>Arukwe, Joseph</creatorcontrib><creatorcontrib>Heywood, Kirsty</creatorcontrib><creatorcontrib>Wilson, Ian</creatorcontrib><creatorcontrib>Wynn, Duncan</creatorcontrib><creatorcontrib>Schafers, Michael</creatorcontrib><creatorcontrib>Levkau, Bodo</creatorcontrib><creatorcontrib>Wagner, Stefan</creatorcontrib><creatorcontrib>Breyholz, Hans-Jörg</creatorcontrib><creatorcontrib>Kopka, Klaus</creatorcontrib><creatorcontrib>GE Healthcare Limited</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Storey, Anthony</au><au>Davis, Julie</au><au>Ricketts, Sally-Ann</au><au>Mendizabal, Marivi</au><au>Cuthbertson, Alan</au><au>Arukwe, Joseph</au><au>Heywood, Kirsty</au><au>Wilson, Ian</au><au>Wynn, Duncan</au><au>Schafers, Michael</au><au>Levkau, Bodo</au><au>Wagner, Stefan</au><au>Breyholz, Hans-Jörg</au><au>Kopka, Klaus</au><aucorp>GE Healthcare Limited</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Diagnostic imaging agents with MMP inhibitory activity</title><date>2012-07-31</date><risdate>2012</risdate><abstract>The present invention relates to the field of diagnostic imaging. Specifically, the invention relates to the diagnostic imaging of diseases where specific matrix metalloproteinases are known to be involved. One embodiment of the invention is a compound having matrix metalloproteinase inhibitory activity suitable for diagnostic imaging. Also disclosed in the present invention is a pharmaceutical composition comprising the diagnostic imaging agent of the invention in a form suitable for mammalian administration. The invention furthermore discloses intermediates in the synthesis of the diagnostic imaging agents of the invention and kits for the preparation of the pharmaceutical composition of the invention. The pharmaceutical composition of the invention may be used in the diagnosis of diseases where specific matrix metalloproteinases are known to be involved.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_grants_08231858 |
| source | USPTO Issued Patents |
| title | Diagnostic imaging agents with MMP inhibitory activity |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T22%3A31%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Storey,%20Anthony&rft.aucorp=GE%20Healthcare%20Limited&rft.date=2012-07-31&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E08231858%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |